搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant CRAL-TRIO domain-containing protein F28H7.8 (F28H7.8) CSB-YP615211CXY
CSB-EP615211CXY
CSB-BP615211CXY
CSB-MP615211CXY
CSB-EP615211CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pig Prothrombin (F2) CSB-YP615212PI
CSB-EP615212PI
CSB-BP615212PI
CSB-MP615212PI
CSB-EP615212PI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Monodelphis domestica Ubiquitin-like protein 4B (UBL4B) CSB-YP615213MUE
CSB-EP615213MUE
CSB-BP615213MUE
CSB-MP615213MUE
CSB-EP615213MUE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pig tRNA wybutosine-synthesizing protein 3 homolog (TYW3) CSB-YP615214PI
CSB-EP615214PI
CSB-BP615214PI
CSB-MP615214PI
CSB-EP615214PI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorokybus atmophyticus NAD (P)H-quinone oxidoreductase subunit 4L, chloroplastic (ndhE), partial CSB-YP615215CWP1
CSB-EP615215CWP1
CSB-BP615215CWP1
CSB-MP615215CWP1
CSB-EP615215CWP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorokybus atmophyticus NAD (P)H-quinone oxidoreductase subunit 5, chloroplastic (ndhF), partial CSB-YP615216CWP
CSB-EP615216CWP
CSB-BP615216CWP
CSB-MP615216CWP
CSB-EP615216CWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorokybus atmophyticus Photosystem I assembly protein ycf3 (ycf3) CSB-YP615217CWP
CSB-EP615217CWP
CSB-BP615217CWP
CSB-MP615217CWP
CSB-EP615217CWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorokybus atmophyticus Apocytochrome f (petA), partial CSB-YP615218CWP1
CSB-EP615218CWP1
CSB-BP615218CWP1
CSB-MP615218CWP1
CSB-EP615218CWP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorokybus atmophyticus 30S ribosomal protein S18, chloroplastic (rps18) CSB-YP615219CWP
CSB-EP615219CWP
CSB-BP615219CWP
CSB-MP615219CWP
CSB-EP615219CWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorokybus atmophyticus Photosystem II reaction center protein L (psbL), partial CSB-YP615220CWP
CSB-EP615220CWP
CSB-BP615220CWP
CSB-MP615220CWP
CSB-EP615220CWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorokybus atmophyticus DNA-directed RNA polymerase subunit beta (rpoB), partial CSB-YP615221CWP
CSB-EP615221CWP
CSB-BP615221CWP
CSB-MP615221CWP
CSB-EP615221CWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorokybus atmophyticus 30S ribosomal protein S3, chloroplastic (rps3) CSB-YP615222CWP
CSB-EP615222CWP
CSB-BP615222CWP
CSB-MP615222CWP
CSB-EP615222CWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pipistrellus rusticus Forkhead box protein G1 (FOXG1) CSB-YP615223PBAF
CSB-EP615223PBAF
CSB-BP615223PBAF
CSB-MP615223PBAF
CSB-EP615223PBAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Simian immunodeficiency virus Protein Rev (rev) CSB-YP615224SBAM
CSB-EP615224SBAM
CSB-BP615224SBAM
CSB-MP615224SBAM
CSB-EP615224SBAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Simian immunodeficiency virus Protein Rev (rev) CSB-YP615225SBAL
CSB-EP615225SBAL
CSB-BP615225SBAL
CSB-MP615225SBAL
CSB-EP615225SBAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Conus litteratus Conotoxin Lt5.11 CSB-YP615226DWB
CSB-EP615226DWB
CSB-BP615226DWB
CSB-MP615226DWB
CSB-EP615226DWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human IQ domain-containing protein J (IQCJ) CSB-YP615227HU
CSB-EP615227HU
CSB-BP615227HU
CSB-MP615227HU
CSB-EP615227HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pan paniscus Tripartite motif-containing protein 5 (TRIM5) CSB-YP615228EQU
CSB-EP615228EQU
CSB-BP615228EQU
CSB-MP615228EQU
CSB-EP615228EQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chara vulgaris NAD (P)H-quinone oxidoreductase subunit 4L, chloroplastic (ndhE), partial CSB-YP615229CBAK1
CSB-EP615229CBAK1
CSB-BP615229CBAK1
CSB-MP615229CBAK1
CSB-EP615229CBAK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chara vulgaris NAD (P)H-quinone oxidoreductase subunit 5, chloroplastic (ndhF), partial CSB-YP615230CBAK
CSB-EP615230CBAK
CSB-BP615230CBAK
CSB-MP615230CBAK
CSB-EP615230CBAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>